Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-10 · accession 0001437749-22-027220 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-14 | 2022-11-10 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +2,798 | 18.8K | +17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-10 | A | A | 700 | $0.00 | 19,510 | D | — | — | (F2) Represents shares issued to the Reporting Person on November 10, 2022, under the Issuer's Amended and Restated 2015 Equity Incentive Plan in payment of board committee meeting attendance fees. |
| 2 | Common | Common Stock | 2022-11-10 | A | A | 2,098 | $0.00 | 18,810 | D | — | — | (F1) Represents shares issued to the Reporting Person on November 10, 2022, under the Issuer's Amended and Restated 2015 Equity Incentive Plan in payment of board meeting attendance fees. |